Profile
| Metric | Value |
|---|---|
| Full Name | Palvella Therapeutics, Inc. |
| Ticker | NASDAQ: PVLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | palvellatx.com |
| Employees | 14 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $102.51 | |
| Price, 1D Change | -0.99% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.72 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$7.83 | |
| EPS, 1Y Change | -100.98% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:80 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PIRS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$7.83 | |
| EPS Estimate | -$3.52 | |
| EPS Est. Change | +55.08% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $102.51 | |
| Price Target | - | $192.00 |
| Price Tgt. Change | - | +87.30% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.01 | -$7.83 | -160.55% | |
| -$3.52 | N/A | +55.08% | |
| -$4.04 | N/A | +48.37% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.43K | $0.00 | -100.00% | |
| - | N/A | - | |
| $28.57K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +689.75% | |
| Price, 3Y | -14.58% | |
| Market Cap, 1Y | +748.88% | |
| Market Cap, 3Y | +985.49% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | -100.00% | |
| EPS, 1Y | -100.98% | |
| EPS, 3Y | +86.18% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $102.51 | |
| SMA 200 | $52.99 | |
| SMA 200 vs Price | -48.30% | |
| SMA 50 | $92.95 | |
| SMA 50 vs Price | -9.32% | |
| Beta | 0.72 | |
| ATR | $8.85 | |
| 14-Day RSI | 55.17 | |
| 10-Day Volatility | 111.83% | |
| 1-Year Volatility | 78.80% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$7.83 | |
| Gross Profit | $0.00 | |
| Gross Margin | - | |
| Operating Profit | -$14.10M | |
| Operating Margin | - | |
| Net Income | -$17.43M | |
| Net Margin | - | |
| EBITDA | -$14.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.19 | |
| 7.33 | ||
| 7.33 | ||
| - | ||
| - | ||
| 27.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 31.37 | ||
| -42.03 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $62.61M | |
| $83.60M | ||
| $88.23M | ||
| $88.23M | ||
| $25.63M | ||
| $12.04M | ||
| Total Debt | $11.94M | |
| $0.00 | ||
| $4.59M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $17.43M | ||
| $14.10M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.84M | ||
| $0.00 | ||
| $87.09M | ||
| Capex | $0.00 | |
| -$10.84M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | ||
| Truist Securities | → | |
| TD Cowen | → | |
| Chardan Capital | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Clear Street | ||
| BTIG | ||
| Craig-Hallum |
Analyst sentiment
Institutional ownership
Screeners with PVLA
Data Sources & References
- PVLA Official Website palvellatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1583648/000119312525276119/0001193125-25-276119-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1583648/000095017025047212/0000950170-25-047212-index.htm
- PVLA Profile on Yahoo Finance finance.yahoo.com/quote/PVLA
- PVLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pvla
FAQ
What is the ticker symbol for Palvella Therapeutics, Inc.?
The ticker symbol for Palvella Therapeutics, Inc. is NASDAQ:PVLA
Does Palvella Therapeutics, Inc. pay dividends?
No, Palvella Therapeutics, Inc. does not pay dividends
What sector is Palvella Therapeutics, Inc. in?
Palvella Therapeutics, Inc. is in the Healthcare sector
What industry is Palvella Therapeutics, Inc. in?
Palvella Therapeutics, Inc. is in the Biotechnology industry
What country is Palvella Therapeutics, Inc. based in?
Palvella Therapeutics, Inc. is headquartered in United States
When did Palvella Therapeutics, Inc. go public?
Palvella Therapeutics, Inc. initial public offering (IPO) was on January 2, 2015
Is Palvella Therapeutics, Inc. in the S&P 500?
No, Palvella Therapeutics, Inc. is not included in the S&P 500 index
Is Palvella Therapeutics, Inc. in the NASDAQ 100?
No, Palvella Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Palvella Therapeutics, Inc. in the Dow Jones?
No, Palvella Therapeutics, Inc. is not included in the Dow Jones index
When was Palvella Therapeutics, Inc. last earnings report?
Palvella Therapeutics, Inc.'s most recent earnings report was on November 11, 2025
When does Palvella Therapeutics, Inc. report earnings?
The next expected earnings date for Palvella Therapeutics, Inc. is March 31, 2026